Garrett Hummel and his 3-year-old son, Calvin, both look at their surgery scars at their home on June 10, 2017, in North Aurora, Ill. Calvin developed infantile nephrotic syndrome and kidney failure as a baby and, after discovering he was a match for Calvin, his father was able to give his left kidney to his son.
Garrett Hummel and his 3-year-old son, Calvin, both look at their surgery scars at their home on June 10, 2017, in North Aurora, Ill. Calvin developed infantile nephrotic syndrome and kidney failure as a baby and, after discovering he was a match for Calvin, his father was able to give his left kidney to his son. Erin Hooley TNS
Garrett Hummel and his 3-year-old son, Calvin, both look at their surgery scars at their home on June 10, 2017, in North Aurora, Ill. Calvin developed infantile nephrotic syndrome and kidney failure as a baby and, after discovering he was a match for Calvin, his father was able to give his left kidney to his son. Erin Hooley TNS

When a toddler needed a transplant, his father stepped up

June 28, 2017 09:00 AM

UPDATED June 28, 2017 09:40 AM

More Videos

  • First treatment that genetically modifies patients’ cells to destroy cancer approved by FDA

    T-cells are one of immune system’s key soldiers, targeting infected or abnormal cells but cancer can block those defenses Now scientists are genetically modifying patients own cells to make them smarter and tougher at seeking out and destroying cancer. One version is called CAR-T cell therapy, T-cells customized to zero in on a patients specific kind of cancer.